Staphylococcus aureus PSMα3 Cross-α Fibril Polymorphism and Determinants of Cytotoxicity.


Journal

Structure (London, England : 1993)
ISSN: 1878-4186
Titre abrégé: Structure
Pays: United States
ID NLM: 101087697

Informations de publication

Date de publication:
03 03 2020
Historique:
received: 28 06 2019
revised: 15 10 2019
accepted: 16 12 2019
pubmed: 11 1 2020
medline: 30 4 2021
entrez: 11 1 2020
Statut: ppublish

Résumé

The phenol-soluble modulin (PSM) peptide family, secreted by Staphylococcus aureus, performs various virulence activities, some mediated by the formation of amyloid fibrils of diverse architectures. Specifically, PSMα1 and PSMα4 structure the S. aureus biofilm by assembling into robust cross-β amyloid fibrils. PSMα3, the most cytotoxic member of the family, assembles into cross-α fibrils in which α helices stack into tightly mated sheets, mimicking the cross-β architecture. Here we demonstrate that massive T cell deformation and death are linked with PSMα3 aggregation and co-localization with cell membranes. Our extensive mutagenesis analyses support the role of positive charges, and especially Lys17, in interactions with the membrane and suggest their regulation by inter- and intra-helical electrostatic interactions within the cross-α fibril. We hypothesize that PSMα3 cytotoxicity is governed by the ability to form cross-α fibrils and involves a dynamic process of co-aggregation with the cell membrane, rupturing it.

Identifiants

pubmed: 31918959
pii: S0969-2126(19)30445-9
doi: 10.1016/j.str.2019.12.006
pii:
doi:

Substances chimiques

Amyloid 0
Bacterial Toxins 0
Protein Aggregates 0
staphylococcal delta toxin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

301-313.e6

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Einav Tayeb-Fligelman (E)

Department of Biology, Technion-Israel Institute of Technology, Haifa 3200003, Israel.

Nir Salinas (N)

Department of Biology, Technion-Israel Institute of Technology, Haifa 3200003, Israel.

Orly Tabachnikov (O)

Department of Biology, Technion-Israel Institute of Technology, Haifa 3200003, Israel.

Meytal Landau (M)

Department of Biology, Technion-Israel Institute of Technology, Haifa 3200003, Israel; Centre for Structural Systems Biology (CSSB), and European Molecular Biology Laboratory (EMBL), Hamburg 22607, Germany. Electronic address: mlandau@technion.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH